Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (noted in metadata as Lifecore Biomedical, Inc., though the filing text identifies Landec Corporation) on March 27, 2007. The report discloses the consolidated financial results for the third quarter of fiscal year 2007, which ended on February 25, 2007.
Key Financial Metrics
The filing text serves as a notification of results and incorporates a press release by reference. It does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within the body of this document. Investors must refer to the attached Exhibit 99.1 (Press Release) for detailed financial data.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period in the text provided. It only confirms the issuance of results for the quarter ended February 25, 2007.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The document strictly references the attached press release for the announcement of results.
Investor Verification Checklist
- Verify the specific revenue and net income figures in the attached Exhibit 99.1 (Press Release).
- Confirm the discrepancy between the metadata company name ("LIFECORE BIOMEDICAL, INC.") and the registrant name in the filing ("Landec Corporation").
- Review the press release for any year-over-year comparisons or guidance not included in this summary.
- Check for any subsequent filings that may update the financial condition reported for the quarter ended February 25, 2007.